How Do You Spell FACTOR XIII DEFICIENCY?

Pronunciation: [fˈaktə ɹˌə͡ʊmən θˈɜːtiːn dɪfˈɪʃənsi] (IPA)

Factor XIII Deficiency is a rare genetic disorder affecting the blood-clotting system. The spelling of this complex medical term can be broken down into its individual sounds using the International Phonetic Alphabet (IPA). It is pronounced /ˈfæk.tər ˌθɜː.tiːn diːˈfɪʃ.ənsi/. The first syllable starts with the voiceless alveolar stop /f/. The second syllable starts with the voiced dental fricative /ð/. The word ends with the voiced alveolar fricative /z/ and the unstressed vowel schwa /ə/. Proper spelling and pronunciation of medical terminology are essential for effective communication between healthcare providers and patients.

FACTOR XIII DEFICIENCY Meaning and Definition

1. Factor XIII deficiency, also known as fibrin stabilizing factor deficiency, is a rare inherited blood disorder characterized by insufficient levels of factor XIII in the blood. Factor XIII is a protein that plays a crucial role in the final stages of blood clotting, aiding in the formation of stable fibrin clots.

   Individuals with factor XIII deficiency are generally asymptomatic until they experience an injury or undergo surgery, which can trigger excessive bleeding. Symptoms can vary in severity, ranging from mild bleeding after minor trauma to life-threatening bleeding episodes. Common manifestations include spontaneous bleeding in the muscles and joints, abnormal bruising, prolonged bleeding after surgery, and delayed wound healing.

   Factor XIII deficiency is caused by mutations in the gene that provides instructions for producing factor XIII. This disorder is inherited in an autosomal recessive manner, meaning that both parents must pass on a copy of the mutated gene for their child to be affected. Incidence is relatively rare, affecting roughly 1 in 2 to 3 million individuals worldwide.

   Diagnosis of factor XIII deficiency typically involves blood tests to measure factor XIII activity levels. Genetic testing may also be conducted to identify the specific mutations responsible for the condition. Treatment primarily involves the administration of factor XIII concentrates or fresh frozen plasma to raise and maintain adequate factor XIII levels in the blood. In some cases, prophylactic treatment may be recommended to prevent bleeding occurrences. With appropriate management, individuals with factor XIII deficiency can lead normal lives.

Common Misspellings for FACTOR XIII DEFICIENCY

• fawctor xii deficiency
• dactor xiii deficiency
• cactor xiii deficiency
• vactor xiii deficiency
• gactor xiii deficiency
• tactor xiii deficiency
• ractor xiii deficiency
• fzctor xiii deficiency
• fsctor xiii deficiency
• fwctor xiii deficiency
• fqctor xiii deficiency
• faxtor xiii deficiency
• favtor xiii deficiency
• faftor xiii deficiency
• fadtor xiii deficiency
• facror xiii deficiency
• facfor xiii deficiency
• facgor xiii deficiency
• facyor xiii deficiency
• fac6or xiii deficiency